Search Within

Advanced Practice Providers

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (61)
  2. Meeting Abstract (56)
  3. Miscellaneous (4)
  4. Research Letter (3)
  5. Review (3)
  6. Conference Paper (2)
  7. Editorial (1)
Groups
  1. Sloan Kettering Institute Postdocs (130)
  2. Department of Medicine (77)
  3. Nursing (68)
  4. Survivorship Research (67)
  5. GSK Faculty (58)
  6. Department of Pathology and Laboratory Medicine (50)

More Groups

People
  1. Ahmet Dogan (22)
  2. Gunjan Shah (17)
  3. Maria Arcila (17)
  4. Alison Moskowitz (15)
  5. Malin Hultcrantz (15)
  6. Maria Palomba (15)

More People

Years
  1. 2025 (2)
  2. 2024 (15)
  3. 2023 (16)
  4. 2022 (19)
  5. 2021 (16)
  6. 2020 (17)

More Years

Publications
  1. Blood (25)
  2. Journal of Clinical Oncology (13)
  3. Annals of Surgical Oncology (11)
  4. Neuro-Oncology (7)
  5. Annals of Surgery (4)
  6. BJU International (3)

More Publications

Publishers
  1. American Society of Hematology (26)
  2. Springer (16)
  3. American Society of Clinical Oncology (13)
  4. Lippincott Williams & Wilkins (11)
  5. Oxford University Press (11)
  6. Elsevier Science, Inc. (9)

More Publishers

Results (130)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients
    Journal Article

    Lin, R. J.; Michaud, L.; Lobaugh, S. M.; Nakajima, R.; Mauguen, A.; Elko, T. A.; Ruiz, J. D.; Maloy, M. A.; Sauter, C. S.; Dahi, P. B.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Extracellular vesicle and particle biomarkers define multiple human cancers
    Journal Article

    Hoshino, A.; Kim, H. S.; Bojmar, L.; Gyan, K. E.; Cioffi, M.; Hernandez, J.; Zambirinis, C. P.; Rodrigues, G.; Molina, H.; Heissel, S.; more...
    Cell (2020)

    Fulltext@MSK | Save
  • Clinical patterns and genomic profiling of recurrent 'ultra-low risk' endometrial cancer
    Journal Article

    Stasenko, M.; Feit, N.; Lee, S. S. K.; Shepherd, C.; Soslow, R. A.; Cadoo, K. A.; Alektiar, K.; Da Silva, E. M.; Martins Sebastião, A. P.; Leitao, M. M. Jr; more...
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Synchronous and metachronous bilateral breast cancer among women with a history of lobular carcinoma in situ
    Meeting Abstract

    Mallory, M. A.; Park, A.; Whiting, K.; Gonen, M.; Gilbert, E.; King, T. A.; Pilewskie, M.
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • The Tyrer–Cuzick model inaccurately predicts invasive breast cancer risk in women with LCIS
    Journal Article

    Valero, M. G.; Zabor, E. C.; Park, A.; Gilbert, E.; Newman, A.; King, T. A.; Pilewskie, M. L.
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Final results of a phase II biomarker-driven study of ruxolitinib in relapsed and refractory T-cell lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Ghione, P.; Jacobsen, E. D.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Hancock, H.; Davey, T.; Obadi, O.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • High complete response rate observed with second-line chemo-immunotherapy with pembrolizumab and GVD (gemcitabine, vinorelbine, and liposomal doxorubicin) in relapsed and refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G. L.; Schoder, H.; Hancock, H.; Davey, T.; Joong, C.; Pomerantz, L.; Jarjies, C.; Kumar, A.; Lahoud, O. B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in combination with multi-morbidity and functional impairment
    Meeting Abstract

    Lin, R. J.; Michaud, L.; Lobaugh, S. M.; Nakajima, R.; Elko, T. A.; Ruiz, J. D.; Sauter, C. S.; Dahi, P. B.; Maloy, M. A.; Perales, M. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in multiple myeloma patients treated with lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Mastey, D.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; Shah, U. A.; Lu, S. X.; Mastey, D.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save